As its name implies, walking pneumonia is a kind of pneumonia (an infection where the air sacs in the lungs fill with fluid ...

In connection with the start of the phase 3 trials of PCV21, Sanofi has expanded its alliance with South Korea-based SK Bio, ...

Infections tend to be most common among older children and adolescents but in 2024 have been rampant among young children, ...

Antimicrobial resistance and serotypes in Streptococcus pneumoniae have been evolving with the widespread use of antibiotics and the introduction of pneumococcal conjugate vaccines (PCV).

Walking pneumonia differs from other respiratory infections like flu or cold because it quickly settles in the chest and can ...

Cases of pneumococcal diseases - a spectrum of bacterial infections young children are at risk of contracting - have surged ...

French pharma major Sanofi says it has entered into a new chapter of the collaboration with South Korean firm SK bioscience ...

Rates of invasive pneumococcal disease are at their highest levels since 2004. While more effective vaccines have been ...